- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
153 results
1043 Exhibit: Ex 1043 Amarin Reports Fourth Quarter and Full Year 2004 Results R...
Document
IPR2022-00215, No. 1043-48 Exhibit - Ex 1043 Amarin Reports Fourth Quarter and Full Year 2004 Results Report (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1009 Exhibit: Ex 1009 Plaintiffs Corrected Post Trial Proposed Findings of Fact and...
Document
IPR2022-00215, No. 1009-10 Exhibit - Ex 1009 Plaintiffs Corrected Post Trial Proposed Findings of Fact and Conclusions of Law Feb 27, 2020 from Amarin Pharma, Inc v Hikma Pharms USA Inc...
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 2
Document
IPR2022-00215, No. 1013-57 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 2 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 11
Document
IPR2022-00215, No. 1013-66 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 11 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1004 Exhibit: Ex 1004 Mori et al, Purified Eicosapentaenoic and Docosahexaenoic...
Document
IPR2022-00215, No. 1004-3 Exhibit - Ex 1004 Mori et al, Purified Eicosapentaenoic and Docosahexaenoic Acids Have Differential Effects on Serum Lipids and Lipoproteins, LDL Particle Size, G...
|
|
Cite Document
1031 Exhibit: Ex 1031 Amarin Supplemental Response to US Patent Office re US P...
Document
IPR2022-00215, No. 1031-36 Exhibit - Ex 1031 Amarin Supplemental Response to US Patent Office re US Patent Application No 13614,111 Jan 11, 2013 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1039 Exhibit: Ex 1039 Original Japanese version of WO 2007142118 to Yokoyama...
Document
IPR2022-00215, No. 1039-44 Exhibit - Ex 1039 Original Japanese version of WO 2007142118 to Yokoyama et al (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1015 Exhibit: Ex 1015 Nozaki et al, Effects of Purified Eicosapentaenoic Acid Ethyl...
Document
IPR2022-00215, No. 1015-16 Exhibit - Ex 1015 Nozaki et al, Effects of Purified Eicosapentaenoic Acid Ethyl Ester on Plasma Lipoproteins in Primary Hypercholesterolemia, 62 Intl J Vitamin Nu...
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 9
Document
IPR2022-00215, No. 1013-64 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 9 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1045 Exhibit: Ex 1045 Yokoyama et al, Effects of eicosapentaenoic acid on cardiov...
Document
IPR2022-00215, No. 1045-50 Exhibit - Ex 1045 Yokoyama et al, Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia Rationale, design, an...
|
|
Cite Document
1040 Exhibit: Ex 1040 US Patent No 6,384,077 to Peet et al
Document
IPR2022-00215, No. 1040-45 Exhibit - Ex 1040 US Patent No 6,384,077 to Peet et al (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1012 Exhibit: Ex 1012 Schmidt et al, Lipid evaluation in HIV 1 positive patients treat...
Document
IPR2022-00215, No. 1012-14 Exhibit - Ex 1012 Schmidt et al, Lipid evaluation in HIV 1 positive patients treated with protease inhibitors, 4 Antiviral Ther 163 170 1999 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1008 Exhibit: Ex 1008 Third Report of the National Cholesterol Education Program ...
Document
IPR2022-00215, No. 1008-9 Exhibit - Ex 1008 Third Report of the National Cholesterol Education Program N CEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestero...
|
|
Cite Document
1047 Exhibit: Ex 1047 Curriculum vitae of Edward A Fisher
Document
IPR2022-00215, No. 1047-52 Exhibit - Ex 1047 Curriculum vitae of Edward A Fisher (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1030 Exhibit: Ex 1030 US Patent Office Interview Summary re US Patent Applicatio...
Document
IPR2022-00215, No. 1030-35 Exhibit - Ex 1030 US Patent Office Interview Summary re US Patent Application No 13614,111 Dec 12, 2012 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
